Literature DB >> 22678360

dSarm/Sarm1 is required for activation of an injury-induced axon death pathway.

Jeannette M Osterloh1, Jing Yang, Timothy M Rooney, A Nicole Fox, Robert Adalbert, Eric H Powell, Amy E Sheehan, Michelle A Avery, Rachel Hackett, Mary A Logan, Jennifer M MacDonald, Jennifer S Ziegenfuss, Stefan Milde, Ying-Ju Hou, Carl Nathan, Aihao Ding, Robert H Brown, Laura Conforti, Michael Coleman, Marc Tessier-Lavigne, Stephan Züchner, Marc R Freeman.   

Abstract

Axonal and synaptic degeneration is a hallmark of peripheral neuropathy, brain injury, and neurodegenerative disease. Axonal degeneration has been proposed to be mediated by an active autodestruction program, akin to apoptotic cell death; however, loss-of-function mutations capable of potently blocking axon self-destruction have not been described. Here, we show that loss of the Drosophila Toll receptor adaptor dSarm (sterile α/Armadillo/Toll-Interleukin receptor homology domain protein) cell-autonomously suppresses Wallerian degeneration for weeks after axotomy. Severed mouse Sarm1 null axons exhibit remarkable long-term survival both in vivo and in vitro, indicating that Sarm1 prodegenerative signaling is conserved in mammals. Our results provide direct evidence that axons actively promote their own destruction after injury and identify dSarm/Sarm1 as a member of an ancient axon death signaling pathway.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22678360      PMCID: PMC5225956          DOI: 10.1126/science.1223899

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  21 in total

1.  Evidence that Wallerian degeneration and localized axon degeneration induced by local neurotrophin deprivation do not involve caspases.

Authors:  J T Finn; M Weil; F Archer; R Siman; A Srinivasan; M C Raff
Journal:  J Neurosci       Date:  2000-02-15       Impact factor: 6.167

Review 2.  Axonal self-destruction and neurodegeneration.

Authors:  Martin C Raff; Alan V Whitmore; John T Finn
Journal:  Science       Date:  2002-05-03       Impact factor: 47.728

Review 3.  Mosaic analysis with a repressible cell marker (MARCM) for Drosophila neural development.

Authors:  T Lee; L Luo
Journal:  Trends Neurosci       Date:  2001-05       Impact factor: 13.837

Review 4.  Wallerian degeneration, wld(s), and nmnat.

Authors:  Michael P Coleman; Marc R Freeman
Journal:  Annu Rev Neurosci       Date:  2010       Impact factor: 12.449

Review 5.  Axon retraction and degeneration in development and disease.

Authors:  Liqun Luo; Dennis D M O'Leary
Journal:  Annu Rev Neurosci       Date:  2005       Impact factor: 12.449

6.  Axotomy-induced axonal degeneration is mediated by calcium influx through ion-specific channels.

Authors:  E B George; J D Glass; J W Griffin
Journal:  J Neurosci       Date:  1995-10       Impact factor: 6.167

7.  A Toll-interleukin 1 repeat protein at the synapse specifies asymmetric odorant receptor expression via ASK1 MAPKKK signaling.

Authors:  Chiou-Fen Chuang; Cornelia I Bargmann
Journal:  Genes Dev       Date:  2004-12-29       Impact factor: 11.361

8.  Absence of Wallerian Degeneration does not Hinder Regeneration in Peripheral Nerve.

Authors:  E R Lunn; V H Perry; M C Brown; H Rosen; S Gordon
Journal:  Eur J Neurosci       Date:  1989       Impact factor: 3.386

9.  Neurites can remain viable after destruction of the neuronal soma by programmed cell death (apoptosis).

Authors:  T L Deckwerth; E M Johnson
Journal:  Dev Biol       Date:  1994-09       Impact factor: 3.582

10.  Prolonged survival of transected nerve fibres in C57BL/Ola mice is an intrinsic characteristic of the axon.

Authors:  J D Glass; T M Brushart; E B George; J W Griffin
Journal:  J Neurocytol       Date:  1993-05
View more
  273 in total

1.  Axon degeneration: A new pathway emerges.

Authors:  Man Tsuey Tse
Journal:  Nat Rev Neurosci       Date:  2012-06-27       Impact factor: 34.870

2.  SARM1, Not MyD88, Mediates TLR7/TLR9-Induced Apoptosis in Neurons.

Authors:  Piyali Mukherjee; Clayton W Winkler; Katherine G Taylor; Tyson A Woods; Vinod Nair; Burhan A Khan; Karin E Peterson
Journal:  J Immunol       Date:  2015-09-30       Impact factor: 5.422

Review 3.  Axon Self-Destruction: New Links among SARM1, MAPKs, and NAD+ Metabolism.

Authors:  Josiah Gerdts; Daniel W Summers; Jeffrey Milbrandt; Aaron DiAntonio
Journal:  Neuron       Date:  2016-02-03       Impact factor: 17.173

Review 4.  Emergence of SARM1 as a Potential Therapeutic Target for Wallerian-type Diseases.

Authors:  Heather S Loring; Paul R Thompson
Journal:  Cell Chem Biol       Date:  2019-11-21       Impact factor: 8.116

5.  Sodium and potassium currents influence Wallerian degeneration of injured Drosophila axons.

Authors:  Bibhudatta Mishra; Ross Carson; Richard I Hume; Catherine A Collins
Journal:  J Neurosci       Date:  2013-11-27       Impact factor: 6.167

Review 6.  New approaches for studying synaptic development, function, and plasticity using Drosophila as a model system.

Authors:  C Andrew Frank; Xinnan Wang; Catherine A Collins; Avital A Rodal; Quan Yuan; Patrik Verstreken; Dion K Dickman
Journal:  J Neurosci       Date:  2013-11-06       Impact factor: 6.167

7.  SARM1 activation triggers axon degeneration locally via NAD⁺ destruction.

Authors:  Josiah Gerdts; E J Brace; Yo Sasaki; Aaron DiAntonio; Jeffrey Milbrandt
Journal:  Science       Date:  2015-04-23       Impact factor: 47.728

Review 8.  Advances in peripheral nerve regeneration.

Authors:  Jami Scheib; Ahmet Höke
Journal:  Nat Rev Neurol       Date:  2013-11-12       Impact factor: 42.937

9.  Activation of the innate signaling molecule MAVS by bunyavirus infection upregulates the adaptor protein SARM1, leading to neuronal death.

Authors:  Piyali Mukherjee; Tyson A Woods; Roger A Moore; Karin E Peterson
Journal:  Immunity       Date:  2013-03-14       Impact factor: 31.745

Review 10.  Axon degeneration: context defines distinct pathways.

Authors:  Matthew J Geden; Mohanish Deshmukh
Journal:  Curr Opin Neurobiol       Date:  2016-05-16       Impact factor: 6.627

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.